Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 558M | 509M | 523M | 493M | 443M |
| Gross Profit | 173M | 152M | 148M | 119M | 108M |
| Operating Income | 47M | 39M | 40M | 21M | 17M |
| EBITDA | 65M | 61M | 60M | 39M | 31M |
| Net Income | 37M | 34M | 32M | 21M | 13M |
| EPS (Diluted) | — | — | — | — | — |
Technology
Live Price
Offline$30.08
+3.33% today
1Y Change
+3.37%
Window
Jun 30, 2025 → Jun 26, 2026
Coverage: 249 bars · Jun 30, 2025 → Jun 26, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
IBEX Limited (IBEX) is a Technology stock with a market cap of $370.00M and listed on NASDAQ. The stock last traded around $30.08 and up 3.4% across the available one-year price window (Jun 30, 2025 → Jun 26, 2026). Baseline metrics include revenue growth of +9.8%, EPS growth of +32.1%, a dividend yield of 0.0%. What stands out right now is revenue +9.8%, EPS +32.1%, free cash flow +0.9% with operating margin 9.0% and ROIC 20.2%. Valuation is more restrained than many high-expectation growth names at P/E 8.4 and price/sales 0.6. Stock Foundry combines IBEX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
IBEX is 14.62 pts behind over the shared 1Y window.
IBEX had 28.01 pts deeper max drawdown than SPY.
IBEX beat SPY in 1 of 2 calendar years shown and trailed in 1.
IBEX
+3.37%
Normalized return
SPY
+17.99%
S&P 500
Excess Return
-14.62 pts
Relative to SPY
IBEX Max Drawdown
-37.14%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for IBEX and SPY.
| Year | IBEX | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -17.18% | +6.71% | -23.89 pts | SPY |
| 2025 | +32.30% | +11.19% | +21.11 pts | IBEX |
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$443.4M
-10.0% YoY
FY Net Income
$13.1M
-39.0% YoY
Free Cash Flow
-$4.7M
-133.7% YoY
Revenue Growth
+9.8%
EPS Growth
+32.1%
Gross Margin
29.6%
Net Margin
7.3%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 558M | 509M | 523M | 493M | 443M |
| Gross Profit | 173M | 152M | 148M | 119M | 108M |
| Operating Income | 47M | 39M | 40M | 21M | 17M |
| EBITDA | 65M | 61M | 60M | 39M | 31M |
| Net Income | 37M | 34M | 32M | 21M | 13M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 15M | 63M | 57M | 49M | 58M |
| Total Assets | 273M | 294M | 293M | 294M | 274M |
| Total Liabilities | 139M | 128M | 143M | 181M | 194M |
| Shareholder Equity | 134M | 166M | 150M | 113M | 81M |
| Total Debt | 70M | 67M | 79M | 106M | 113M |
| Net Debt | 54M | 4M | 21M | 57M | 55M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
16M
-59.8% YoY
Capital Expenditures
21M
+19.7% YoY
Free Cash Flow
5M
-133.7% YoY
Key ratios
Gross Margin
29.6%
Operating Margin
9.0%
Net Margin
7.3%
ROE
31.9%
Debt / Equity
0.42x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.